Oragenics, Inc. (OGEN)
0.4815
-0.02
(-3.68%)
USD |
NYAM |
Oct 08, 12:36
Oragenics Price : 0.4815 for Oct. 8, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 07, 2026 | 0.4999 | 0.50 | 0.4895 | 0.4999 | 11689.00 |
| Oct 06, 2026 | 0.4858 | 0.4874 | 0.4751 | 0.485 | 12301.00 |
| Oct 05, 2026 | 0.478 | 0.5049 | 0.478 | 0.4861 | 42469.00 |
| Oct 02, 2026 | 0.48 | 0.50 | 0.48 | 0.4876 | 15429.00 |
| Oct 01, 2026 | 0.4892 | 0.5189 | 0.48 | 0.48 | 32440.00 |
| Sep 30, 2026 | 0.4797 | 0.50 | 0.468 | 0.4918 | 14371.00 |
| Sep 29, 2026 | 0.49 | 0.4901 | 0.4605 | 0.48 | 42635.00 |
| Sep 28, 2026 | 0.509 | 0.509 | 0.4605 | 0.4716 | 33313.00 |
| Sep 25, 2026 | 0.52 | 0.52 | 0.4826 | 0.4878 | 13348.00 |
| Sep 24, 2026 | 0.49 | 0.503 | 0.49 | 0.503 | 17417.00 |
| Sep 23, 2026 | 0.52 | 0.53 | 0.4851 | 0.486 | 41071.00 |
| Sep 22, 2026 | 0.5198 | 0.5250 | 0.4965 | 0.52 | 25261.00 |
| Sep 21, 2026 | 0.4825 | 0.5199 | 0.4753 | 0.519 | 37853.00 |
| Sep 18, 2026 | 0.4962 | 0.52 | 0.4767 | 0.4767 | 43015.00 |
| Sep 17, 2026 | 0.495 | 0.5229 | 0.4902 | 0.519 | 48946.00 |
| Sep 16, 2026 | 0.50 | 0.5163 | 0.48 | 0.50 | 54726.00 |
| Sep 15, 2026 | 0.487 | 0.4988 | 0.4756 | 0.4876 | 25530.00 |
| Sep 14, 2026 | 0.484 | 0.499 | 0.4775 | 0.499 | 24657.00 |
| Sep 11, 2026 | 0.503 | 0.5036 | 0.478 | 0.478 | 67020.00 |
| Sep 10, 2026 | 0.5051 | 0.5053 | 0.5025 | 0.5033 | 9235.00 |
| Sep 09, 2026 | 0.52 | 0.52 | 0.5052 | 0.515 | 5353.00 |
| Sep 08, 2026 | 0.51 | 0.5223 | 0.51 | 0.5223 | 12633.00 |
| Sep 04, 2026 | 0.4992 | 0.52 | 0.4992 | 0.51 | 8732.00 |
| Sep 03, 2026 | 0.5061 | 0.5234 | 0.496 | 0.4985 | 22885.00 |
| Sep 02, 2026 | 0.508 | 0.5329 | 0.4973 | 0.5061 | 25807.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.42 |
| Alnylam Pharmaceuticals, Inc. | 219.53 |
| Savara, Inc. | 4.695 |
| Vericel Corp. | 40.46 |
| Biogen, Inc. | 216.95 |
Price Related Metrics
| Price to Book Value | 0.5919 |
| Earnings Yield | -744.1% |
| Market Cap | 2.172M |